None listed
Conditions
Interventions
Intervention1: IminoNorm: 0.25mg of IminoNorm powder,once a day when the volunteer is at the site on visit 4,5,6 and 7 to be taken orally along with 200ml of water
Control Intervention1: Glucose: 50gm
Sponsors
Phynova Group
Eligibility
Inclusion criteria
Inclusion criteria: Healthy Volunteers with a BMI between 18 and 25 Non-Diabetic or any pre-diabetic conditions demonstrated by a fasting blood sugar between 3.9 to 5.5 mmols/L (70 - 100mg/dL).Not on any diabetic or insulin resistance medication
Exclusion criteria
Exclusion criteria: Abnormal laboratory values at screening. Pregnant or Lactating women Subjects with any cardio-vascular diseases Subjects otherwise judged by the PI not fit to participate in the study Any past significant medical history Any Psychiatric disorder or on any such medications Any malignancy or history of malignancies Any known hypersensitivity or allergy Recent participation (within the last 3 months) in any other clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of IP on the Glycaemic Index of common carbohydratesTimepoint: Blood samples will be taken during -15mins, 0mins, 15mins, 30mins, 45mins, 60mins, 90mins and 120mins during each visit | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety of the IPTimepoint: Any AEs and SAEs to be recorded, reported and followed up during the time of the participation in the study. | — |
Countries
India
Contacts
Public ContactDrRohit Kulkarni
Pulse Diagnostic Centre
Outcome results
None listed